References
- Clark OH, Lal G. Thyroid, parathyroid and adrenal. In: Brunicardi FC, Andersen DK, Billiar TR, et al. editors. Schwartz’s principles of surgery. 9th ed. Philadelphia (PA): The McGraw-Hill Companies; 2010.
- Jameson JL, Weetman AP. Disorders of thyroid gland. In: Lango DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL, Loscalzo J, editors. Harrison’s principles of internal medicine. 18th ed. Philadelphia (PA): The McGraw-Hill Companies; 2012, pp. 2911–2940.
- Xing M, Westra WH, Tufano RP, et al. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab. 2005;90:6373–6379.
- Iyer NG, Shaha AR. Controversies and challenges in the management of well-differentiated thyroid cancer. Indian J Surg. 2009;71:299–307.
- Henry J, Gramatica L, Denizot A, et al. Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma. Langenbecks Arch Chir. 1998;383:167–169.
- Fonseca E, Soares P, Rossi S, et al. Prognostic factors in thyroid carcinomas. Verhandlungen Deutschen Gesellschaft Pathol. 1997;81:82.
- Hay I, Bergstralh E, Goellner J, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993;114:1050.
- Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97:418–428.
- Carty SE, Cooper DS, Doherty GM, et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer: the American Thyroid Association Surgery Working Group with Participation from the American Association of Endocrine Surgeons, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society. Thyroid. 2009;19:1153–1158.
- Ito Y, Miyauchi A, Kihara M, Higashiyama T, Kobayashi K, Miya A. Prognostic significance of young age in papillary thyroid carcinoma: Analysis of 5,733 patients with 150 months' median follow-up. Endocr J. 2014;61:491–497.
- Jalai Nadoushan MR, Davati A, Alahyari K. Expression of MDM2 in papillary thyroid carcinoma and its correlation with prognostic factors. Ofogh-e-Danesh GMUHS J. 2010;16:62–67.
- Lee CW, Roh J-L, Gong G, et al. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck. Ann Surg Oncol. 2015;22:117–124.
- Ryu IS, Song CI, Choi S-H, et al. Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma. Ann Surg Oncol. 2014;21:277–283.
- Nixon IJ, Wang LY, Ganly I, et al. Outcomes for patients with papillary thyroid cancer who do not undergo prophylactic central neck dissection. Br J Surg. 2016;103:218–225.
- Lee YM, Yoon JH, Yi O, et al. Familial history of non-medullary thyroid cancer is an independent prognostic factor for tumor recurrence in younger patients with conventional papillary thyroid carcinoma. J Surg Oncol. 2014;109:168–173.
- Ito Y, Fukushima M, Kihara M, et al. Investigation of the prognosis of patients with papillary thyroid carcinoma by tumor size. Endocr J. 2012;59:457–464.
- Yip J, Orlov S, Orlov D, et al. Predictive value of metastatic cervical lymph node ratio in papillary thyroid carcinoma recurrence. Head Neck. 2013;35:592–598.